If you work in life sciences, whether in pharma, diagnostics, or vaccines, Federally Qualified Health Centers (FQHCs) might not be on your radar. Many manufacturers focus their...
Why the Life Science Industry Should Care About the Proposed HTI-2 Rule
In an era where data fluidity is transforming healthcare, life sciences manufacturers must stay attuned to evolving Health IT policies given that many of these policies have...
Untapped Potential: Pharma’s Role in Easing EHR Documentation Burdens
It’s no secret that many physicians have come to view the electronic health record (EHR) as a necessary evil – a tool marketed in the initial, heady days of Meaningful Use as a...
- 1
